Literature DB >> 344006

Antianginal efficacy of oral therapy with isosorbide dinitrate capsules. Prolonged benefit shown by exercise testing in patients with ischemic heart disease.

G Lee, D T Mason, E A Amsterdam, R R Miller, A N DeMaria.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 344006     DOI: 10.1378/chest.73.3.327

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

1.  Isosorbide dinitrate attenuated coronary artery spasm during general anesthesia for non-cardiac surgery.

Authors:  H Komatsu; H Mitsuhata; S Matsumoto; J Hasegawa
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

Review 2.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.

Authors:  S Silber; A C Vogler; K H Krause; K Theisen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.

Authors:  J Whittington; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

Review 5.  Short and long-acting oral nitrates for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

6.  Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.

Authors:  M A James; P R Walker; M Papouchado; P R Wilkinson
Journal:  Br Heart J       Date:  1985-06

Review 7.  Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.

Authors:  U Elkayam; W S Aronow
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.